The Hepatitis C Transplant Collaborative

NCT04493385 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2026-01-22

No results posted yet for this study

Summary

In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.

Conditions

  • Transplant; Failure, Heart
  • Hepatitis C

Sponsors & Collaborators

  • Baylor Research Institute

    lead OTHER

Principal Investigators

  • Shelley A Hall, MD FACC · BSWRI

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-16
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04493385 on ClinicalTrials.gov